Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta-blockade effects on exercise capacity and BNP in diastolic heart failure
2004-004169-13Phase 4Terminated
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Apr 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of bisoprolol in heart failure with preserved ejection fraction (HFpEF), sponsored by Manchester University NHS Foundation Trust. Primary endpoint: Change in plasma BNP from baseline. Started Apr 2005; status: terminated.
02
Drugs
bisoprolol
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on 2004-004169-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004169-13.